Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Structural Basis of Toll-Like Receptor 3 Signaling with Double-Stranded RNA
Lin Liu,1
Istvan Botos,1
Yan Wang,2
Joshua N. Leonard,2
Joseph Shiloach,3
David M. Segal,2
David R. Davies1*
Abstract:
Toll-like receptor 3 (TLR3) recognizes double-stranded RNA (dsRNA),a molecular signature of most viruses, and triggers inflammatoryresponses that prevent viral spread. TLR3 ectodomains (ECDs)dimerize on oligonucleotides of at least 40 to 50 base pairsin length, the minimal length required for signal transduction.To establish the molecular basis for ligand binding and signaling,we determined the crystal structure of a complex between twomouse TLR3-ECDs and dsRNA at 3.4 angstrom resolution. Each TLR3-ECDbinds dsRNA at two sites located at opposite ends of the TLR3horseshoe, and an intermolecular contact between the two TLR3-ECDC-terminal domains coordinates and stabilizes the dimer. Thisjuxtaposition could mediate downstream signaling by dimerizingthe cytoplasmic Toll interleukin-1 receptor (TIR) domains. Theoverall shape of the TLR3-ECD does not change upon binding todsRNA.
1 Laboratory of Molecular Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA. 2 Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD20892, USA. 3 Biotechnology Unit, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
* To whom correspondence should be addressed: david.davies{at}nih.gov
The editors suggest the following Related Resources on Science sites:
In Science Signaling
EDITORS' CHOICE
Valda J. Vinson (22 April 2008) Sci. Signal.1 (16), ec140.
[DOI: 10.1126/stke.116ec140] |Abstract »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Sisters in arms: myeloid and tubular epithelial cells shape renal innate immunity.
T. Hato, T. M. El-Achkar, and P. C. Dagher (2013)
Am J Physiol Renal Physiol
304, F1243-F1251
|Abstract »|Full Text »|PDF »
Structural Reorganization of the Toll-Like Receptor 8 Dimer Induced by Agonistic Ligands.
H. Tanji, U. Ohto, T. Shibata, K. Miyake, and T. Shimizu (2013)
Science
339, 1426-1429
|Abstract »|Full Text »|PDF »
Molecular Pathways: Toll-like Receptors in the Tumor Microenvironment--Poor Prognosis or New Therapeutic Opportunity.
L. A. Ridnour, R. Y. S. Cheng, C. H. Switzer, J. L. Heinecke, S. Ambs, S. Glynn, H. A. Young, G. Trinchieri, and D. A. Wink (2013)
Clin. Cancer Res.
19, 1340-1346
|Abstract »|Full Text »|PDF »
Inhibition of Toll-Like Receptor-Mediated Inflammation In Vitro and In Vivo by a Novel Benzoxaborole.
C. Dong, H. Sexton, A. Gertrudes, T. Akama, S. Martin, C. Virtucio, C.-W. Chen, X. Fan, A. Wu, W. Bu, et al. (2013)
J. Pharmacol. Exp. Ther.
344, 436-446
|Abstract »|Full Text »|PDF »
Structural basis for cytosolic double-stranded RNA surveillance by human oligoadenylate synthetase 1.
Cleaved/Associated TLR3 Represents the Primary Form of the Signaling Receptor.
F. Toscano, Y. Estornes, F. Virard, A. Garcia-Cattaneo, A. Pierrot, B. Vanbervliet, M. Bonnin, M. J. Ciancanelli, S.-Y. Zhang, K. Funami, et al. (2013)
J. Immunol.
190, 764-773
|Abstract »|Full Text »|PDF »
CD11b/CD18 (Mac-1) Is a Novel Surface Receptor for Extracellular Double-Stranded RNA To Mediate Cellular Inflammatory Responses.
H. Zhou, J. Liao, J. Aloor, H. Nie, B. C. Wilson, M. B. Fessler, H.-M. Gao, and J.-S. Hong (2013)
J. Immunol.
190, 115-125
|Abstract »|Full Text »|PDF »
Proteolytic Processing Regulates Toll-like Receptor 3 Stability and Endosomal Localization.
Leucine-rich Repeat 11 of Toll-like Receptor 9 Can Tightly Bind to CpG-containing Oligodeoxynucleotides, and the Positively Charged Residues Are Critical for the High Affinity.
X. Pan, J. Yue, G. Ding, B. Li, X. Liu, X. Zheng, M. Yu, J. Li, W. Jiang, C. Wu, et al. (2012)
J. Biol. Chem.
287, 30596-30609
|Abstract »|Full Text »|PDF »
Identification and functional characterization of the nascent RNA contacting residues of the hepatitis C virus RNA-dependent RNA polymerase.
Cleavage of Toll-like receptor 3 by cathepsins B and H is essential for signaling.
A. Garcia-Cattaneo, F.-X. Gobert, M. Muller, F. Toscano, M. Flores, A. Lescure, E. Del Nery, and P. Benaroch (2012)
PNAS
109, 9053-9058
|Abstract »|Full Text »|PDF »
Structural Insights into the Assembly of Large Oligomeric Signalosomes in the Toll-Like Receptor-Interleukin-1 Receptor Superfamily.
RNA Synthesis by the Brome Mosaic Virus RNA-Dependent RNA Polymerase in Human Cells Reveals Requirements for De Novo Initiation and Protein-Protein Interaction.
C. V. Subba-Reddy, B. Tragesser, Z. Xu, B. Stein, C. T. Ranjith-Kumar, and C. C. Kao (2012)
J. Virol.
86, 4317-4327
|Abstract »|Full Text »|PDF »
Mice, men and the relatives: cross-species studies underpin innate immunity.
M. Yamashita, S. Chattopadhyay, V. Fensterl, Y. Zhang, and G. C. Sen (2012)
J. Immunol.
188, 2825-2833
|Abstract »|Full Text »|PDF »
Probing the Arabidopsis Flagellin Receptor: FLS2-FLS2 Association and the Contributions of Specific Domains to Signaling Function.
W. Sun, Y. Cao, K. Jansen Labby, P. Bittel, T. Boller, and A. F. Bent (2012)
PLANT CELL
24, 1096-1113
|Abstract »|Full Text »|PDF »
Structural Basis of TLR5-Flagellin Recognition and Signaling.
S.-i. Yoon, O. Kurnasov, V. Natarajan, M. Hong, A. V. Gudkov, A. L. Osterman, and I. A. Wilson (2012)
Science
335, 859-864
|Abstract »|Full Text »|PDF »
Intrinsic danger: activation of Toll-like receptors in rheumatoid arthritis.
Activation of Endothelial Toll-Like Receptor 3 Impairs Endothelial Function.
S. Zimmer, M. Steinmetz, T. Asdonk, I. Motz, C. Coch, E. Hartmann, W. Barchet, S. Wassmann, G. Hartmann, and G. Nickenig (2011)
Circ. Res.
108, 1358-1366
|Abstract »|Full Text »|PDF »
Small molecule Toll-like receptor 7 agonists localize to the MHC class II loading compartment of human plasmacytoid dendritic cells.
C. Russo, I. Cornella-Taracido, L. Galli-Stampino, R. Jain, E. Harrington, Y. Isome, S. Tavarini, C. Sammicheli, S. Nuti, M. L. Mbow, et al. (2011)
Blood
117, 5683-5691
|Abstract »|Full Text »|PDF »
Nucleic acid recognition by Toll-like receptors is coupled to stepwise processing by cathepsins and asparagine endopeptidase.
S. E. Ewald, A. Engel, J. Lee, M. Wang, M. Bogyo, and G. M. Barton (2011)
J. Exp. Med.
208, 643-651
|Abstract »|Full Text »|PDF »
A Point Mutation in the Amino Terminus of TLR7 Abolishes Signaling without Affecting Ligand Binding.
C. Iavarone, K. Ramsauer, A. V. Kubarenko, J. C. Debasitis, I. Leykin, A. N. R. Weber, O. M. Siggs, B. Beutler, P. Zhang, G. Otten, et al. (2011)
J. Immunol.
186, 4213-4222
|Abstract »|Full Text »|PDF »
Cleavage and activation of a Toll-like receptor by microbial proteases.
M. R. de Zoete, L. I. Bouwman, A. M. Keestra, and J. P. M. van Putten (2011)
PNAS
108, 4968-4973
|Abstract »|Full Text »|PDF »
A Functional Toll-Like Receptor 3 Gene (TLR3) May Be a Risk Factor for Tick-borne Encephalitis Virus (TBEV) Infection.
E. Kindberg, S. Vene, A. Mickiene, A. Lundkvist, L. Lindquist, and L. Svensson (2011)
The Journal of Infectious Disease
203, 523-528
|Abstract »|Full Text »|PDF »
I. Jelinek, J. N. Leonard, G. E. Price, K. N. Brown, A. Meyer-Manlapat, P. K. Goldsmith, Y. Wang, D. Venzon, S. L. Epstein, and D. M. Segal (2011)
J. Immunol.
186, 2422-2429
|Abstract »|Full Text »|PDF »
CD14 is a coreceptor of Toll-like receptors 7 and 9.
C. L. Baumann, I. M. Aspalter, O. Sharif, A. Pichlmair, S. Bluml, F. Grebien, M. Bruckner, P. Pasierbek, K. Aumayr, M. Planyavsky, et al. (2010)
J. Exp. Med.
207, 2689-2701
|Abstract »|Full Text »|PDF »
A Naturally Occurring Variant in Human TLR9, P99L, Is Associated with Loss of CpG Oligonucleotide Responsiveness.
A. V. Kubarenko, S. Ranjan, A. Rautanen, T. C. Mills, S. Wong, F. Vannberg, M. Neumaier, I. Bekeredjian-Ding, A. V. S. Hill, P. Ahmad-Nejad, et al. (2010)
J. Biol. Chem.
285, 36486-36494
|Abstract »|Full Text »|PDF »
Dimerization of Toll-like Receptor 3 (TLR3) Is Required for Ligand Binding.
Y. Wang, L. Liu, D. R. Davies, and D. M. Segal (2010)
J. Biol. Chem.
285, 36836-36841
|Abstract »|Full Text »|PDF »
Secretion of the Human Toll-like Receptor 3 Ectodomain Is Affected by Single Nucleotide Polymorphisms and Regulated by Unc93b1.
R. Qi, S. Hoose, J. Schreiter, K. V. Sawant, R. Lamb, C. T. Ranjith-Kumar, J. Mills, L. S. Mateo, J. L. Jordan, and C. C. Kao (2010)
J. Biol. Chem.
285, 36635-36644
|Abstract »|Full Text »|PDF »
Adaptation and Constraint at Toll-Like Receptors in Primates.
A Role for Toll-like Receptor 3 Variants in Host Susceptibility to Enteroviral Myocarditis and Dilated Cardiomyopathy.
C. Gorbea, K. A. Makar, M. Pauschinger, G. Pratt, J. L. F. Bersola, J. Varela, R. M. David, L. Banks, C.-H. Huang, H. Li, et al. (2010)
J. Biol. Chem.
285, 23208-23223
|Abstract »|Full Text »|PDF »
Structural basis for solute transport, nucleotide regulation, and immunological recognition of Neisseria meningitidis PorB.
Rapid Heteromerization and Phosphorylation of Ligand-activated Plant Transmembrane Receptors and Their Associated Kinase BAK1.
B. Schulze, T. Mentzel, A. K. Jehle, K. Mueller, S. Beeler, T. Boller, G. Felix, and D. Chinchilla (2010)
J. Biol. Chem.
285, 9444-9451
|Abstract »|Full Text »|PDF »
Sulforaphane Suppresses Oligomerization of TLR4 in a Thiol-Dependent Manner.
H. S. Youn, Y. S. Kim, Z. Y. Park, S. Y. Kim, N. Y. Choi, S. M. Joung, J. A. Seo, K.-M. Lim, M.-K. Kwak, D. H. Hwang, et al. (2010)
J. Immunol.
184, 411-419
|Abstract »|Full Text »|PDF »
Toll-like Receptor Polymorphisms and Age-Related Macular Degeneration: Replication in Three Case-Control Samples.
Y. Cho, J. J. Wang, E. Y. Chew, F. L. Ferris III, P. Mitchell, C.-C. Chan, and J. Tuo (2009)
Invest. Ophthalmol. Vis. Sci.
50, 5614-5618
|Abstract »|Full Text »|PDF »
Long Double-Stranded RNA Induces an Antiviral Response Independent of IFN Regulatory Factor 3, IFN-{beta} Promoter Stimulator 1, and IFN.
S. J. DeWitte-Orr, D. R. Mehta, S. E. Collins, M. S. Suthar, M. Gale Jr., and K. L. Mossman (2009)
J. Immunol.
183, 6545-6553
|Abstract »|Full Text »|PDF »
Toll-like Receptors of the Ascidian Ciona intestinalis: PROTOTYPES WITH HYBRID FUNCTIONALITIES OF VERTEBRATE TOLL-LIKE RECEPTORS.
N. Sasaki, M. Ogasawara, T. Sekiguchi, S. Kusumoto, and H. Satake (2009)
J. Biol. Chem.
284, 27336-27343
|Abstract »|Full Text »|PDF »
Toll-Like Receptor 3 Mediates Establishment of an Antiviral State against Hepatitis C Virus in Hepatoma Cells.
N. Wang, Y. Liang, S. Devaraj, J. Wang, S. M. Lemon, and K. Li (2009)
J. Virol.
83, 9824-9834
|Abstract »|Full Text »|PDF »
Identification of an N-Terminal Recognition Site in TLR9 That Contributes to CpG-DNA-Mediated Receptor Activation.
M. E. Peter, A. V. Kubarenko, A. N. R. Weber, and A. H. Dalpke (2009)
J. Immunol.
182, 7690-7697
|Abstract »|Full Text »|PDF »
Therapeutic Targeting of Toll-Like Receptors for Infectious and Inflammatory Diseases and Cancer.
L. A. J. O'Neill, C. E. Bryant, and S. L. Doyle (2009)
Pharmacol. Rev.
61, 177-197
|Abstract »|Full Text »|PDF »
Essential Roles of Hydrophobic Residues in Both MD-2 and Toll-like Receptor 4 in Activation by Endotoxin.
N. Resman, J. Vasl, A. Oblak, P. Pristovsek, T. L. Gioannini, J. P. Weiss, and R. Jerala (2009)
J. Biol. Chem.
284, 15052-15060
|Abstract »|Full Text »|PDF »
The RIG-I-like Receptor LGP2 Recognizes the Termini of Double-stranded RNA.
X. Li, C. T. Ranjith-Kumar, M. T. Brooks, S. Dharmaiah, A. B. Herr, C. Kao, and P. Li (2009)
J. Biol. Chem.
284, 13881-13891
|Abstract »|Full Text »|PDF »
Human plasmacytoid dendritic cells are unresponsive to bacterial stimulation and require a novel type of cooperation with myeloid dendritic cells for maturation.
D. Piccioli, C. Sammicheli, S. Tavarini, S. Nuti, E. Frigimelica, A. G.O. Manetti, A. Nuccitelli, S. Aprea, S. Valentini, E. Borgogni, et al. (2009)
Blood
113, 4232-4239
|Abstract »|Full Text »|PDF »
Small interfering RNA-induced TLR3 activation inhibits blood and lymphatic vessel growth.
W. G. Cho, R. J. C. Albuquerque, M. E. Kleinman, V. Tarallo, A. Greco, M. Nozaki, M. G. Green, J. Z. Baffi, B. K. Ambati, M. De Falco, et al. (2009)
PNAS
106, 7137-7142
|Abstract »|Full Text »|PDF »
Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses.
Agonist and Antagonist Recognition by RIG-I, a Cytoplasmic Innate Immunity Receptor.
C. T. Ranjith-Kumar, A. Murali, W. Dong, D. Srisathiyanarayanan, R. Vaughan, J. Ortiz-Alacantara, K. Bhardwaj, X. Li, P. Li, and C. C. Kao (2009)
J. Biol. Chem.
284, 1155-1165
|Abstract »|Full Text »|PDF »
Targeting Poly(I:C) to the TLR3-Independent Pathway Boosts Effector CD8 T Cell Differentiation through IFN-{alpha}/{beta}.
S. M. Ngoi, M. G. Tovey, and A. T. Vella (2008)
J. Immunol.
181, 7670-7680
|Abstract »|Full Text »|PDF »
Vaccinia Virus Subverts a Mitochondrial Antiviral Signaling Protein-Dependent Innate Immune Response in Keratinocytes through Its Double-Stranded RNA Binding Protein, E3.
L. Deng, P. Dai, T. Parikh, H. Cao, V. Bhoj, Q. Sun, Z. Chen, T. Merghoub, A. Houghton, and S. Shuman (2008)
J. Virol.
82, 10735-10746
|Abstract »|Full Text »|PDF »
Antigen Recognition by Variable Lymphocyte Receptors.
B. W. Han, B. R. Herrin, M. D. Cooper, and I. A. Wilson (2008)
Science
321, 1834-1837
|Abstract »|Full Text »|PDF »